AgomAb Therapeutics' Leadership Team includes Reginald Brys and 9 others.
Andrea Sáez
Head of Portfolio Management
Ellen Lefever
General Counsel
Paolo Michieli
Chief Scientific Officer
Paul van der Horst
Chief Business Officer
Philippe Wiesel
Chief Medical Officer
Ramon Bosser
Head of R&D Operations
Reginald Brys
Head of Research
Tim Knotnerus
CEO
Tolga Hassan
Chief Financial Officer
Torsten Dreier
Chief Development Officer
View all